All News IGM Biosciences, Inc.

Equities

IGMS

US4495851085

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
9.34 ^USD	-7.71%		-7.25%	+12.39%

09/05	RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk	MT
08/05	Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk	09/05	MT
Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000	09/05	MT
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update	09/05	GL
IGM Biosciences, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	09/05	CI
IGM Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference	07/05	GL
IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets	17/04	MT
IGM Biosciences Announces Refocusing of Sanofi Collaboration	17/04	GL
IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration	17/04	CI
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum	10/04	GL
North American Morning Briefing : Stocks Set for -2-	28/03	DJ
HC Wainwright Adjusts IGM Biosciences Price Target to $12 From $7, Maintains Neutral Rating	12/03	MT
Earnings Flash (IGMS) IGM BIOSCIENCES Reports Q4 Revenue $651,000	08/03	MT
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	08/03	GL
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	08/03	AQ
IGM Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/03	CI
IGM Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03	CI
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023	15/02	AQ
North American Morning Briefing : Stock Futures -2-	12/02	DJ
RBC Upgrades IGM Biosciences to Outperform From Sector Perform, Boosts Price Target to $21 From $9; Speculative Risk Kept	09/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News IGM Biosciences, Inc.

Equities

IGMS

US4495851085

All News

Filters